| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |